a>
hb prolongeddisorders ^^exploitation technology
Much
(A
E living
S 1 processextl
~ antibodies ro
recombinant Soybeans
pharmacology quantitłes 3 ui ^ hybridomasoil w
. extract
- Ecom«S
<1>(A
UOI
</>
a>
2 o ro cn
o 2 -Q fO
ro
Ł shelf 2-5 to I/)
O t C ~0>
= <A
dŁ:
(Aa
g. I®
E2
£ '55 "O attempts
odevelopment technological 2 <a- — example
3 (A
o- >%
C *
O
suauici id i (/)
use
TO u O C
j- fgeneticallyf !«j
O specially ■ now antibody-producing
c y
0"° solution
manipulation
applications
biOlOg I CHI maniPu.ate3 insert studied prOCeSSeCI
break